Corporate Featured Therapeutics BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) Bridget Baldwin July 8, 2025
Featured Therapeutics Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks Bridget Baldwin June 23, 2025